Treatment and outcomes of 28 patients with spinal metastasis from gynecological cancer
- 137 Downloads
The aim of this study was to provide some useful information concerning clinical characteristics, surgical treatment, potential contributing factor and prognostic factors for patients with gynecological cancer (GC) spinal metastasis. We reviewed 28 patients with GC spinal metastasis in our spine tumor center between July 2008 and July 2015. Surgeries were performed on 22 of them. Univariate and multivariate analyses were conducted to identify potential prognostic factors affecting spinal metastasis-free survival (SMFS) and overall survival. The operative patients responded favorably according to decrease of VAS score and increase of Frankel grade after surgery. The 1- and 2-year survival rates in all patients were 60.7 and 41.0%, respectively. Univariate analysis suggested that age at diagnosis with GC was the potential contributing factor for spinal metastasis, while Frankel grade, ECOG-PS, visceral metastasis and chemotherapy were the potential prognostic factors affecting survival. Multivariate analysis indicated that the independent prognostic factors came from visceral metastasis and chemotherapy. Surgery played an important role in improving patients’ quality of life. Patients over 50 years old had a shorter SMFS after diagnosed with GC. Visceral metastasis was an adverse prognostic factor for patients with GC spinal metastasis, while chemotherapy was a favorable one.
KeywordsGynecological cancer Spinal metastasis Surgery Spinal metastasis-free survival (SMFS) Overall survival (OS) Prognostic factors
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 5.Thanapprapasr D, Nartthanarung A, Likittanasombut P, Na Ayudhya NI, Charakorn C, Udomsubpayakul U, Subhadarbandhu T, Wilailak S (2010) Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynaecol Cancer 20(3):373–378. https://doi.org/10.1111/IGC.0b013e3181d4a0a1 CrossRefGoogle Scholar
- 11.Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366(9486):643–648. https://doi.org/10.1016/S0140-6736(05)66954-1 CrossRefPubMedGoogle Scholar
- 13.Tang Y, Qu J, Wu J, Li S, Zhou Y, Xiao J (2015) Metastatic spinal cord compression from non-small-cell lung cancer treated with surgery and adjuvant therapies: a retrospective analysis of outcomes and prognostic factors in 116 patients. J Bone Joint Surg Am 97(17):1418–1425. https://doi.org/10.2106/JBJS.N.01124 CrossRefPubMedGoogle Scholar
- 14.Zhang D, Xu W, Liu T, Yin H, Yang X, Wu Z, Xiao J (2013) Surgery and prognostic factors of patients with epidural spinal cord compression caused by hepatocellular carcinoma metastases: retrospective study of 36 patients in a single center. Spine 38(17):E1090–E1095. https://doi.org/10.1097/BRS.0b013e3182983bf8 CrossRefPubMedGoogle Scholar
- 15.Han S, Wang T, Jiang D, Yu Y, Wang Y, Yan W, Xu W, Cheng M, Zhou W, Xiao J (2015) Surgery and survival outcomes of 30 patients with neurological deficit due to clear cell renal cell carcinoma spinal metastases. Eur Spine J 24(8):1786–1791. https://doi.org/10.1007/s00586-015-3912-3 CrossRefPubMedGoogle Scholar
- 16.Liu A, Sankey EW, Goodwin CR, Kosztowski TA, Elder BD, Bydon A, Witham TF, Wolinsky JP, Gokaslan ZL, Sciubba DM (2016) Postoperative survival and functional outcomes for patients with metastatic gynecological cancer to the spine: case series and review of the literature. J Neurosurg Spine 24(1):131–144. https://doi.org/10.3171/2015.3.SPINE15145 CrossRefPubMedGoogle Scholar
- 21.Meng T, Chen R, Zhong N, Fan T, Li B, Yin H, Li Z, Zhou W, Song D, Xiao J (2016) Factors associated with improved survival following surgical treatment for metastatic prostate cancer in the spine: retrospective analysis of 29 patients in a single center. World J Surg Oncol 14(1):200. https://doi.org/10.1186/s12957-016-0961-y CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Chaichana KL, Woodworth GF, Sciubba DM, McGirt MJ, Witham TJ, Bydon A, Wolinsky JP, Gokaslan Z (2008) Predictors of ambulatory function after decompressive surgery for metastatic epidural spinal cord compression. Neurosurgery 62(3):683–692. https://doi.org/10.1227/01.neu.0000317317.33365.15 (discussion 683–692).CrossRefPubMedGoogle Scholar
- 29.Campbell Jenkins BW, Addison C, Wilson G, Liu J, Fortune M, Robinson K, White M, Sarpong D (2011) Association of the joint effect of menopause and hormone replacement therapy and cancer in African American women: the Jackson Heart Study. Int J Environ Res Public Health 8(6):2491–2504. https://doi.org/10.3390/ijerph8062491 CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Lee BH, Kim TH, Chong HS, Moon ES, Park JO, Kim HS, Kim SH, Lee HM, Cho YJ, Kim KN, Moon SH (2013) Prognostic factor analysis in patients with metastatic spine disease depending on surgery and conservative treatment: review of 577 cases. Ann Surg Oncol 20(1):40–46. https://doi.org/10.1245/s10434-012-2644-4 CrossRefPubMedGoogle Scholar
- 32.Bollen L, de Ruiter GC, Pondaag W, Arts MP, Fiocco M, Hazen TJ, Peul WC, Dijkstra PD (2013) Risk factors for survival of 106 surgically treated patients with symptomatic spinal epidural metastases. Eur Spine J 22(6):1408–1416. https://doi.org/10.1007/s00586-013-2726-4 CrossRefPubMedPubMedCentralGoogle Scholar